Search by Drug Name or NDC

    NDC 31722-0078-01 Theophylline 450 mg/1 Details

    Theophylline 450 mg/1

    Theophylline is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Camber Pharmaceuticals, Inc.. The primary component is THEOPHYLLINE ANHYDROUS.

    Product Information

    NDC 31722-0078
    Product ID 31722-078_05c7eb1d-0b79-ee46-e063-6294a90abfe4
    Associated GPIs
    GCN Sequence Number 000095
    GCN Sequence Number Description theophylline anhydrous TAB ER 12H 450 MG ORAL
    HIC3 A1B
    HIC3 Description XANTHINES
    GCN 00416
    HICL Sequence Number 000025
    HICL Sequence Number Description THEOPHYLLINE ANHYDROUS
    Brand/Generic Generic
    Proprietary Name Theophylline
    Proprietary Name Suffix n/a
    Non-Proprietary Name Theophylline
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 450
    Active Ingredient Units mg/1
    Substance Name THEOPHYLLINE ANHYDROUS
    Labeler Name Camber Pharmaceuticals, Inc.
    Pharmaceutical Class Methylxanthine [EPC], Xanthines [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA217422
    Listing Certified Through 2024-12-31

    Package

    NDC 31722-0078-01 (31722007801)

    NDC Package Code 31722-078-01
    Billing NDC 31722007801
    Package 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-078-01)
    Marketing Start Date 2023-09-08
    NDC Exclude Flag N
    Pricing Information N/A